What Can I Take for Heartburn After Chemo?

Several medications can relieve heartburn during and after chemotherapy, ranging from over-the-counter antacids to prescription-strength acid suppressors. The catch is that not all of them pair safely with every cancer treatment. Proton pump inhibitors, the most powerful option, can interfere with how your body absorbs certain targeted cancer drugs, so what works best for your stomach may need to be weighed against what works best for your treatment. That makes this a conversation worth having with your oncology team before you grab something off the pharmacy shelf.

Why Chemotherapy Causes Heartburn in the First Place

Heartburn and acid reflux are not listed among the most dramatic chemotherapy side effects, so they tend to get less attention than nausea or hair loss. But they are surprisingly common. In one study of pancreatic cancer patients receiving chemotherapy, about 40% met the diagnostic criteria for gastroesophageal reflux disease based on a standardized symptom score.¹ That is a much higher rate than you would expect in the general population, and it points to something more than coincidence.

Chemotherapy drugs can irritate the lining of the esophagus and stomach directly. Some agents are specifically documented to cause esophageal mucosal injury, alongside better-known culprits like anti-inflammatory painkillers and certain antibiotics.² Beyond direct damage, research suggests that cancer and its treatment can disrupt normal gastric motility, meaning the stomach does not contract and empty the way it should. When food sits too long, acid has more opportunity to splash upward into the esophagus.³

Chemotherapy itself is not always the only factor at play. Many treatment regimens include dexamethasone, a steroid given to prevent nausea. In a study tracking side effects from dexamethasone used alongside moderately emetogenic chemo, roughly 27% of patients reported moderate-to-severe indigestion or upper abdominal discomfort in the week following treatment.⁴ So the heartburn you feel might be partly from the chemo itself, partly from a support medication, and partly from the way cancer changes how your gut operates. All of those threads converge in the same burning sensation behind your breastbone.

Antacids for Quick Relief

Antacids like Maalox, Tums, and similar products are the most accessible starting point. They neutralize stomach acid on contact and can ease mild heartburn within minutes. The relief is short-lived, usually measured in hours, and they do not do much for ongoing or severe reflux. But they are a reasonable first step when heartburn flares up between treatments.

One concern people naturally have is whether swallowing an antacid messes with their cancer drugs. For at least one commonly used chemo agent, capecitabine, the answer appears to be no. A pharmacokinetic study in cancer patients showed that taking Maalox at the same time as capecitabine did not meaningfully change how the drug was absorbed, either when the antacid was taken immediately after or two hours later.⁵ That is reassuring, but capecitabine is just one medication. If you are on a different regimen, the interaction picture can look very different, which is why the “ask your oncologist” refrain is not just boilerplate advice here.

H2 Blockers Like Famotidine

Famotidine (sold as Pepcid) and related H2 receptor blockers reduce acid production rather than just neutralizing what is already there. They kick in slower than antacids but last longer, making them useful for more sustained relief. In cancer care, famotidine has a specific track record. A controlled trial in patients receiving cisplatin-based chemotherapy found that famotidine significantly reduced damage to the stomach lining compared to placebo, and that the pH of gastric juice stayed higher in the famotidine group, meaning less acid was present during the vulnerable post-chemo period.⁶

H2 blockers suppress acid less aggressively than proton pump inhibitors, which can actually be an advantage. Because they leave some acid in the stomach, they are less likely to interfere with drugs that need an acidic environment to dissolve properly. For mild-to-moderate heartburn that does not respond well to antacids alone, famotidine is often a practical middle ground.

Proton Pump Inhibitors and Their Trade-Offs

Proton pump inhibitors like omeprazole (Prilosec), esomeprazole (Nexium), and pantoprazole (Protonix) are the strongest acid suppressors available and the most widely prescribed for persistent heartburn. They shut down acid production at the source and are effective at healing irritated esophageal tissue. For cancer patients with significant reflux, PPIs often provide the most reliable symptom control.¹

The problem is that PPIs do their job almost too well, and in cancer care the consequences of near-total acid suppression ripple outward. Long-term PPI use in cancer patients raises concerns about bone fractures, kidney problems, gut infections, and deficiencies in iron and magnesium.⁷ These risks exist for anyone who takes PPIs for months or years, but cancer patients may be more vulnerable because chemotherapy itself can strain the same systems.

There is also an infection angle. One study of lymphoma patients found that PPI use was an independent risk factor for febrile neutropenia, a dangerous condition where a patient with a low white blood cell count develops a fever. Among those hospitalized for febrile neutropenia, about three-quarters were taking PPIs.⁸ The suspected mechanism involves changes to the gut’s bacterial environment when acid is suppressed. This does not mean PPIs are off the table for every patient, but it does mean oncologists increasingly think of PPIs as medications to use at the lowest effective dose for the shortest reasonable time, rather than something to take indefinitely “just in case.”

When Acid Suppression Undermines Cancer Treatment

This is where heartburn management in cancer patients gets genuinely complicated. Many newer cancer drugs are designed to be taken as pills rather than infusions, and a number of them rely on stomach acid to dissolve and be absorbed properly. When a PPI eliminates most of that acid, the drug may not make it into your bloodstream at the intended concentration.

The evidence is clearest for certain tyrosine kinase inhibitors. Erlotinib, gefitinib, and pazopanib have all shown a demonstrated loss of efficacy when patients are simultaneously taking PPIs. The interaction is driven by the simple fact that these drugs are weak bases that need an acidic stomach to dissolve. Results are more conflicting for other oral cancer drugs, including capecitabine and CDK 4/6 inhibitors, where some studies see an interaction and others do not.⁹ There is also a newer concern involving immune checkpoint inhibitors, where PPIs may alter the gut microbiome in ways that dampen the immune response the drugs are designed to unleash.⁹

The practical takeaway is that if you are on an oral targeted therapy or immunotherapy, your oncologist may prefer you manage heartburn with an H2 blocker or antacids rather than a PPI. If a PPI is genuinely necessary, adjusting timing or switching to a less potent option might help. This is not a decision to make on your own, because the stakes involve whether your cancer treatment works as intended.

Sucralfate as an Alternative Approach

Sucralfate works differently from acid-suppressing drugs. Rather than reducing acid production, it forms a protective coating over irritated tissue in the stomach and esophagus, essentially acting as a bandage. This makes it an interesting option for cancer patients because it sidesteps the acid-suppression problems entirely.

A prospective study of 98 patients receiving chemotherapy tested sucralfate as both treatment and prevention. Before starting sucralfate, about half the patients had gastrointestinal symptoms including heartburn, nausea, and cramping during their chemo cycles. After beginning sucralfate therapy, symptoms improved in roughly nine out of ten of those affected. Looking at the full group, there was a statistically significant decrease in both heartburn and nausea during the period of sucralfate use.¹⁰ Sucralfate does require a prescription in most places, and it needs to be taken on an empty stomach to coat properly, but for people who cannot tolerate PPIs or whose cancer regimen rules them out, it is worth discussing.

When Heartburn Is Actually Something Else

One of the trickier aspects of managing heartburn during cancer treatment is that the burning sensation you feel might not be garden-variety acid reflux. Chemo suppresses your immune system and damages mucosal barriers, creating conditions where other problems can mimic heartburn.

Candida esophagitis, a fungal infection of the esophagus, is one of the more common mimics. It causes pain with swallowing, a burning sensation in the chest, and sometimes the feeling of food getting stuck. Cancer patients are at heightened risk because chemotherapy, steroids, broad-spectrum antibiotics, and even PPIs themselves all contribute to an environment where Candida can overgrow.¹¹ There is a certain irony here: the very medication you take for heartburn can increase your risk of developing a condition that feels like heartburn. Treatment involves antifungal medication, not acid suppression, so getting the right diagnosis matters.

Drug-induced esophageal injury is another possibility. Chemotherapy agents, along with many supportive medications, can directly damage the esophageal lining when pills linger in the esophagus. A careful medication history and, sometimes, an endoscopy can identify this pattern.¹²

Perhaps the most important mimic to know about involves certain chemotherapy drugs called fluoropyrimidines, which include 5-fluorouracil and capecitabine. These drugs can occasionally cause coronary vasospasm, a sudden tightening of the arteries supplying the heart. The resulting chest pain or tightness can feel remarkably like heartburn. Because this is a cardiac event, not a stomach problem, treating it with antacids is not just ineffective but dangerously misleading.¹³ If you experience new or worsening chest discomfort during fluoropyrimidine treatment, especially if it comes with shortness of breath, sweating, or a sense that something feels different from your usual heartburn, get evaluated promptly.

Lifestyle Adjustments That Help

Medication is usually the backbone of heartburn management during chemo, but basic behavioral changes can reduce how often you need it. Eating smaller, more frequent meals puts less pressure on the lower esophageal sphincter, the valve that is supposed to keep acid in your stomach. Staying upright for at least two to three hours after eating and elevating the head of your bed by a few inches help gravity do its job at night. Avoiding known triggers like citrus, tomato-based foods, coffee, alcohol, and fatty meals also makes a difference, though many chemo patients already find their appetite and food preferences changing enough that the trigger foods become less tempting on their own.

One lesser-known consideration involves how you take your pills. If your treatment includes oral medications, swallowing them with a full glass of water and remaining upright afterward reduces the chance of the pill lodging in the esophagus and causing local irritation. This is particularly relevant given that drug-induced esophageal injury is a recognized problem in patients taking multiple daily medications.

Complementary therapies have drawn some research interest as well. A systematic review and meta-analysis of auricular acupoint therapy, a technique involving stimulation of specific points on the outer ear, found that it reduced the incidence of sour regurgitation and belching in breast cancer patients undergoing chemotherapy.¹⁴ The effect sizes were promising, though this remains an area where more research would be useful. It is unlikely to replace medication for significant heartburn, but some patients find it helpful as an add-on, particularly if they are trying to minimize drug use.

Talking to Your Treatment Team

Heartburn during chemotherapy tends to be underreported. Patients often view it as a minor complaint compared to the larger picture of cancer treatment, and clinicians are focused on managing the more immediately dangerous side effects. But persistent reflux affects your quality of life, your nutrition, and potentially your willingness to continue treatment on schedule.

When you bring up heartburn with your oncologist or oncology nurse, a few pieces of information make the conversation more productive. Note when the heartburn tends to happen relative to your chemo cycle, because timing helps narrow the cause. Mention any new medications you have started, including steroids, antibiotics, or over-the-counter supplements. And be specific about the sensation: burning that radiates up to your throat points more toward classic reflux, while pain centered in the chest, difficulty swallowing, or a feeling that food is catching all suggest something that needs further workup.

Your team can then match the right intervention to your situation. For someone on intravenous chemo with no oral targeted drugs, a PPI might be perfectly appropriate. For someone taking erlotinib, an H2 blocker or sucralfate might be a smarter choice. For someone whose “heartburn” turns out to be Candida esophagitis, neither acid suppressor would help at all. The right answer depends on the full picture, and your treatment team is the only group that has it.

How Long Heartburn Tends to Last

For many patients, chemo-related heartburn is episodic, flaring in the days around treatment and easing as the cycle progresses. If your heartburn tracks closely with your infusion schedule, that pattern itself is useful information, since it suggests the chemo or its accompanying medications are the primary driver. Once treatment ends, these symptoms often improve within a few weeks as the stomach lining heals and normal motility returns.

Some patients, though, find that heartburn persists well after their last cycle. Chemotherapy can cause lasting changes to the stomach’s mucosal lining and to the nerves that coordinate digestion. If heartburn continues for more than a month or two after finishing treatment, it is worth revisiting with your doctor rather than assuming it will resolve on its own. An endoscopy at that point can rule out structural damage, infection, or other complications, and it can guide a more targeted management plan going forward.